Agile Therapeutics (AGRX) PT Raised to $8 at RBC Capital
Tweet
Share
E-mailGet Alerts AGRX Hot Sheet
Price: $1.51 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
RBC Capital analyst Randall Stanicky raised the price target on Agile Therapeutics (NASDAQ: AGRX) to $8.00 (from $5.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Okta, Inc (OKTA) PT Raised to $165 at JPMorgan
- Flux Power Holdings (FLUX) PT Lowered to $1.60 at Roth/MKM
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
